ACTIVE

APOTHEEK ROGGEN ZAVENTEM

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-15,4 k €-6 971,8 %over 1 year
Gross margin173,3 k €-17,8 %over 1 year
Equity311,1 k €-4,7 %over 1 year
Workforce1,8 ETP0,0 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK ROGGEN ZAVENTEM is a Public limited company incorporated in 1991. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Zaventem. It employs on average 1,8 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0443.149.052
Incorporation
01/02/1991
Legal form
Public limited company
Registered office
Vilvoordelaan 72
1930 Zaventem · FlandreSee on map
Contributed capital
71 889,12 €
Latest accounts
31/12/2025
Average workforce
1,8 ETP
Joint committees (1)
  • 313
Signals
Solid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

20252024202320222021
Income statement
Gross margin173,3 k €210,8 k €168,7 k €216,4 k €190,4 k €
EBITDA22,1 k €66,7 k €43,7 k €110,5 k €86,1 k €
Operating result-88,1 €19 k €26,1 k €93,2 k €66,2 k €
Net result-15,4 k €224,3 €16,8 k €86,2 k €55,3 k €
Balance sheet
Equity311,1 k €326,6 k €326,3 k €334,6 k €342,4 k €
Total assets643,2 k €704,9 k €591,9 k €628,2 k €633,2 k €
Cash38 k €68,5 k €123 k €149,1 k €123,7 k €
Debts329,1 k €375,2 k €262,7 k €291 k €288,2 k €
Other
Workforce1,8 ETP1,8 ETP1,6 ETP1,4 ETP1,4 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 19 ended

Active mandates

R2 FARMA

Managing director · 0842.118.663

Represented by Leen Roggen

Active
Tim Roosens

Director

Active

Ended mandates

R2 FARMA

Managing director · since 24 mai 2017 · until 24 mai 2023 · 0842.118.663

Represented by Leen Roggen

Ended
R2 FARMA

Managing director · since 24 mai 2017 · until 24 mai 2023 · 0842.118.663

Represented by Leen Roggen

Ended
Tim Roosens

Director · since 24 mai 2017 · until 24 mai 2023

Ended
R2 FARMA

Managing director · since 02 janvier 2012 · 0842.118.663

Represented by LEEN ROGGEN

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date13/08/202631/07/202516/07/202429/08/202314/07/202227/08/2021
General meeting29/05/202620/06/202521/06/202424/05/202325/05/202226/05/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202529/05/202613/08/2026DutchPDF
Abridged model31/12/202420/06/202531/07/2025DutchPDF
Abridged model31/12/202321/06/202416/07/2024DutchPDF
Abridged model31/12/202224/05/202329/08/2023DutchPDF
Abridged model31/12/202125/05/202214/07/2022DutchPDF
Abridged model31/12/202026/05/202127/08/2021DutchPDF
Abridged model31/12/201908/09/202017/09/2020DutchPDF
Abridged model31/12/201822/05/201918/06/2019DutchPDF
Abridged model31/12/201713/06/201806/07/2018DutchPDF
Abridged model31/12/201614/06/201706/07/2017DutchPDF
Abridged model31/12/201525/05/201624/06/2016DutchPDF
Abridged model31/12/201427/05/201506/08/2015DutchPDF
Abridged model31/12/201328/05/201406/06/2014DutchPDF
Abridged model31/12/201222/05/201323/05/2013DutchPDF
Abridged model31/12/201130/08/201231/08/2012DutchPDF
Abridged model31/12/201009/08/201110/08/2011DutchPDF
Abridged model31/12/200928/05/201020/08/2010DutchPDF
Abridged model31/12/200829/05/200920/08/2009DutchPDF
Abridged model31/12/200730/05/200821/11/2008DutchPDF
Abridged model31/12/200625/05/200730/11/2007DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 19 ended

Active mandates

R2 FARMA

Managing director · 0842.118.663

Represented by Leen Roggen

Active
Tim Roosens

Director

Active

Ended mandates

R2 FARMA

Managing director · since 24 mai 2017 · until 24 mai 2023 · 0842.118.663

Represented by Leen Roggen

Ended
R2 FARMA

Managing director · since 24 mai 2017 · until 24 mai 2023 · 0842.118.663

Represented by Leen Roggen

Ended
Tim Roosens

Director · since 24 mai 2017 · until 24 mai 2023

Ended
R2 FARMA

Managing director · since 02 janvier 2012 · 0842.118.663

Represented by LEEN ROGGEN

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates07/02/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - BENAMING - ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates02/08/2018
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates20/01/2012
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Other06/01/2012
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Other06/01/2012
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …)
    PDF
  • Mandates16/12/2009
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/02/2004
    ONTSLAGEN - BENOEMINGEN
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-15,4 k €↓
  2. 2024
    Annual accounts 2024224,3 €↓
  3. 2023
    Annual accounts 202316,8 k €↓
  4. 2023
    Name changeApotheek Roggen Zaventem
  5. 2022
    Annual accounts 202286,2 k €↑
  6. 2021
    Annual accounts 202155,3 k €↑
  7. 2021
    Name changeLiefarm
  8. 2020
    Annual accounts 202051,4 k €↑
  9. 2019
    Annual accounts 201916 k €↓
  10. 2018
    Annual accounts 201826,2 k €↑
  11. 2017
    Annual accounts 201710,8 k €↓
  12. 2016
    Annual accounts 201613 k €↑
  13. 2015
    Annual accounts 2015-3,6 k €↓
  14. 2014
    Annual accounts 201429,6 k €↓
  15. 2013
    Annual accounts 201340,7 k €↑
  16. 2012
    Annual accounts 20126,8 k €↓
  17. 2011
    Annual accounts 201186,3 k €↑
  18. 2010
    Annual accounts 201051,4 k €↑
  19. 2009
    Annual accounts 2009-4,1 k €↓
  20. 2008
    Annual accounts 20089,2 k €↑
  21. 2007
    Annual accounts 20075 k €↓
  22. 2006
    Annual accounts 20066,3 k €
  23. 01/02/1991
    IncorporationPublic limited company